hex-clinical-trial

Status

GENETIC-AF is currently enrolling patients in U.S., Canada and Europe

150 Patients enrolled as of January 18, 2017

Phase 2B interim efficacy analysis outcome anticipated in third quarter of 2017 (Guidance as of January 18, 2017)